Table 1 of Papadopoulou, Mol Vis 2018; 24:890-901.


Table 1. Protein carbonyl level and concentration change versus age in CAT, PEX, POAG and PXG.

Sample Ocular Disease Experimental values Tukey's multiple comparisons test1 Adjusted P-value / samples (n1/n2) Signifi-cance degree
A. Rate of protein carbonyl level increase per age versus disease
    Slope rate values (± SE)  
    from Figure 1A (in nmoles carbonyls ml-1 per 5-year interval) CAT vs. PEX <0.0001 (33/31) ****
      CAT vs. POAG <0.0001 (33/19) ****
AH CAT 0.803 ± 0.060 CAT vs. PXG <0.0001 (33/17) ****
  PEX 1.770 ± 0.110 PEX vs. POAG =0.2021 (31/19) ns2
  POAG 2.049 ± 0.127 PEX vs. PXG <0.0001 (31/17) ****
  PXG 2.489 ± 0.096 POAG vs. PXG =0.0146 (19/17) *
    from Figure 1B (in nmoles carbonyls mg-1 protein per 5-year interval) CAT vs. PEX <0.0001 (20/19) ****
      CAT vs. POAG =0.0328 (20/17) *
AH CAT 4.939 ± 0.310 CAT vs. PXG =0.2351 (20/18) ns
  PEX 8.768 ± 0.423 PEX vs. POAG =0.0002 (19/17) ***
  POAG 6.403 ± 0.476 PEX vs. PXG <0.0001 (19/18) ****
  PXG 5.921 ± 0.234 POAG vs. PXG =0.8056 (17/18) ns
    from Figure 2 (in nmoles carbonyls mg-1 protein per 5-year interval) CAT vs. PEX <0.0001 (33/31) ****
      CAT vs. POAG <0.0001 (33/19) ****
LECs/ CAT 1.506 ± 0.116 CAT vs. PXG <0.0001 (33/17) ****
capsule PEX 4.524 ± 0.137 PEX vs. POAG =0.1425 (31/19) ns
  POAG 5.048 ± 0.139 PEX vs. PXG <0.0001 (31/17) ****
  PXG 8.364 ± 0.322 POAG vs. PXG <0.0001 (19/17) ****
B. Protein concentration versus disease (non-age dependent)
    Mean concentration (± SE)  
    from values for horizontal straight lines in Figure 3 (in mg protein ml-1) CAT vs. PEX =0.1225 (20/19) ns
      CAT vs. POAG <0.0001 (20/17) ****
AH CAT 0.16 ± 0.0074 CAT vs. PXG <0.0001 (20/18) ****
  PEX 0.23 ± 0.0093 PEX vs. POAG =0.0003 (19/17) ***
  POAG 0.34 ± 0.0136 PEX vs. PXG <0.0001 (19/18) ****
  PXG 0.42 ± 0.0162 POAG vs. PXG =0.0303 (17/18) *